Several studies have questioned the safety and effectiveness of a tight glycemic control by infusion of insulin or glucose insulin potassium (GIK), especially in critically ill patients such as those with acute MI, providing conflicting results [30–32]. This evidence concerns the gene INS and myocardial infarction.